# Artivion, Inc.: filings

AORT · NYSE · CIK 784199 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aort.md) · [Financials](/companies/aort/financials.md) · [Filings](/companies/aort/filings.md) · [Insiders](/companies/aort/insiders.md)

## Reports and events: 322 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 949, 8-K 221, 144 95, SC 13G/A 56, 10-Q 53, 4/A 35, 5 34, 3 29, CT ORDER 21, 425 20, DEF 14A 19, 10-K 18, SC 13G 16, SD 13, DEFA14A 12, ARS 10, S-8 9, SCHEDULE 13G/A 9, 3/A 8, CORRESP 8, 8-K/A 6, UPLOAD 6, EFFECT 5, S-3 4, SC TO-T/A 4, D 3, PRE 14A 3, S-3ASR 3, S-3/A 2, SC 13D 2, SCHEDULE 13G 2, 10-K/A 1, 10-Q/A 1, 424B3 1, 8-A12B/A 1, DEL AM 1, S-4 1, SCHEDULE 13D/A 1, SC TO-C 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 13:57 ET | [10-Q](/filings/0001628280-26-054746.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054746 |
| 2026-08-06 | 16:08 ET | [8-K](/filings/0001628280-26-054294.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054294 |
| 2026-05-18 | 07:06 ET | [8-K](/filings/0001628280-26-035798.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-035798 |
| 2026-05-15 | 15:13 ET | [8-K](/filings/0001628280-26-035507.md) | 5.07 Shareholder vote results | 0001628280-26-035507 |
| 2026-05-08 | 10:56 ET | [10-Q](/filings/0001628280-26-032620.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032620 |
| 2026-05-07 | 16:10 ET | [8-K](/filings/0001628280-26-032097.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-032097 |
| 2026-04-01 | 16:18 ET | [DEF 14A](/filings/0001999371-26-007510.md) | Proxy statement, period 2026-05-12 | 0001999371-26-007510 |
| 2026-02-18 | 16:14 ET | [10-K](/filings/0001628280-26-009046.md) | Annual report, period 2025-12-31 | 0001628280-26-009046 |
| 2026-02-12 | 16:10 ET | [8-K](/filings/0001628280-26-007674.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-007674 |
| 2025-11-07 | 11:41 ET | [10-Q](/filings/0001628280-25-050502.md) | Quarterly report, period 2025-09-30 | 0001628280-25-050502 |
| 2025-11-06 | 16:09 ET | [8-K](/filings/0001628280-25-050164.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-050164 |
| 2025-09-29 | 16:26 ET | [8-K](/filings/0001628280-25-043099.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-043099 |
| 2025-09-15 | 07:58 ET | [8-K](/filings/0000784199-25-000145.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000784199-25-000145 |
| 2025-08-12 | 16:23 ET | [SCHEDULE 13D/A](/filings/0001214659-25-011863.md) | Ownership report, active investor, amended | 0001214659-25-011863 |
| 2025-08-11 | 13:18 ET | [8-K](/filings/0000784199-25-000136.md) | 5.02 Departure or appointment of officers or directors | 0000784199-25-000136 |
| 2025-08-08 | 11:30 ET | [10-Q](/filings/0001628280-25-039166.md) | Quarterly report, period 2025-06-30 | 0001628280-25-039166 |
| 2025-08-07 | 16:09 ET | [8-K](/filings/0001628280-25-038873.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038873 |
| 2025-05-29 | 18:01 ET | [8-K](/filings/0000784199-25-000129.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-25-000129 |
| 2025-05-16 | 14:32 ET | [8-K](/filings/0000784199-25-000083.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000784199-25-000083 |
| 2025-05-14 | 16:05 ET | [8-K](/filings/0000784199-25-000080.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-25-000080 |
| 2025-05-06 | 15:10 ET | [10-Q](/filings/0000784199-25-000074.md) | Quarterly report, period 2025-03-31 | 0000784199-25-000074 |
| 2025-05-05 | 16:08 ET | [8-K](/filings/0000784199-25-000069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-25-000069 |
| 2025-04-01 | 16:46 ET | [DEF 14A](/filings/0001999371-25-003629.md) | Proxy statement, period 2025-05-13 | 0001999371-25-003629 |
| 2025-02-28 | 14:28 ET | [10-K](/filings/0000784199-25-000029.md) | Annual report, period 2024-12-31 | 0000784199-25-000029 |
| 2025-02-24 | 16:08 ET | [8-K](/filings/0000784199-25-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-25-000012 |
| 2024-12-23 | 16:04 ET | [8-K](/filings/0000784199-24-000265.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-24-000265 |
| 2024-12-09 | 08:05 ET | [8-K](/filings/0000784199-24-000254.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-24-000254 |
| 2024-12-09 | 07:00 ET | [8-K](/filings/0000784199-24-000253.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-24-000253 |
| 2024-11-08 | 15:10 ET | [10-Q](/filings/0000784199-24-000243.md) | Quarterly report, period 2024-09-30 | 0000784199-24-000243 |
| 2024-11-07 | 16:09 ET | [8-K](/filings/0000784199-24-000234.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-24-000234 |
| 2024-08-09 | 11:47 ET | [10-Q](/filings/0000784199-24-000215.md) | Quarterly report, period 2024-06-30 | 0000784199-24-000215 |
| 2024-08-08 | 16:06 ET | [8-K](/filings/0000784199-24-000211.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-24-000211 |
| 2024-07-01 | 16:13 ET | [8-K](/filings/0000784199-24-000207.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000784199-24-000207 |
| 2024-05-17 | 16:14 ET | [8-K](/filings/0000784199-24-000184.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000784199-24-000184 |
| 2024-05-16 | 17:05 ET | [8-K](/filings/0000784199-24-000181.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0000784199-24-000181 |
| 2024-05-07 | 12:07 ET | [10-Q](/filings/0000784199-24-000172.md) | Quarterly report, period 2024-03-31 | 0000784199-24-000172 |
| 2024-05-06 | 16:14 ET | [8-K](/filings/0000784199-24-000169.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-24-000169 |
| 2024-04-01 | 16:56 ET | [DEF 14A](/filings/0001999371-24-004301.md) | Proxy statement, period 2024-05-14 | 0001999371-24-004301 |
| 2024-02-23 | 17:06 ET | [10-K](/filings/0000784199-24-000033.md) | Annual report, period 2023-12-31 | 0000784199-24-000033 |
| 2024-02-15 | 16:09 ET | [8-K](/filings/0000784199-24-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-24-000013 |
| 2024-01-18 | 16:12 ET | [8-K](/filings/0000950157-24-000061.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950157-24-000061 |
| 2023-12-06 | 16:23 ET | [8-K](/filings/0000784199-23-000155.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000784199-23-000155 |
| 2023-11-03 | 14:56 ET | [10-Q](/filings/0000784199-23-000150.md) | Quarterly report, period 2023-09-30 | 0000784199-23-000150 |
| 2023-11-02 | 16:10 ET | [8-K](/filings/0000784199-23-000146.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-23-000146 |
| 2023-08-08 | 16:17 ET | [8-K](/filings/0000784199-23-000139.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000784199-23-000139 |
| 2023-08-04 | 15:00 ET | [10-Q](/filings/0000784199-23-000134.md) | Quarterly report, period 2023-06-30 | 0000784199-23-000134 |
| 2023-08-03 | 16:11 ET | [8-K](/filings/0000784199-23-000130.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-23-000130 |
| 2023-05-19 | 12:26 ET | [8-K](/filings/0000784199-23-000092.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000784199-23-000092 |
| 2023-05-05 | 14:56 ET | [10-Q](/filings/0000784199-23-000088.md) | Quarterly report, period 2023-03-31 | 0000784199-23-000088 |
| 2023-05-04 | 16:11 ET | [8-K](/filings/0000784199-23-000084.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-23-000084 |

Page 1 of 7. [Older](/companies/aort/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:31 ET. No prices; not investment advice.